---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-038882"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2024-04-01T23:59:59+00:00"
generated_at: "2026-06-04T04:26:59.816595+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Acasti Pharma updates corporate presentation; no material new information disclosed

## Summary
- Updated corporate presentation dated April 1, 2024, furnished as Exhibit 99.1.
- Presentation covers company overview and NASDAQ listing (ACST).
- No financial results, guidance, or operational milestones were announced.
- Presentation is available for investor reference on the company's IR page.

## SEC filing metadata
- accession: 0000950170-24-038882
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2024-04-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000095017024038882/0000950170-24-038882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000095017024038882/acst-20240401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-038882
- JSON: https://secwatch.observer/filing/0000950170-24-038882.json
- Plain text: https://secwatch.observer/filing/0000950170-24-038882.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.